K. H. Vincent Lau

Statistics

Publications

Citations

560

H-Index

Active since

2012

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Multiple Myeloma Research Foundation

Wayne State University

Boston Medical Center

K. H. Vincent Lau is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology pharmacotherapy, and multiple myeloma therapy.

ORCID

Publications per year

2012–2023

Publications

Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma

Rachid Baz, Thomas G. Martin, Hui‐Yi Lin et al. · Blood · 2016 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab

K. H. Vincent Lau, Aditya Kumar, Irene Yang et al. · Muscle & Nerve · 2016 · 94 citations

Life Sciences, Immunology, Pharmacology +17

Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases

Charles C. L. Tong, Eric C. Ko, Max W. Sung et al. · PLoS ONE · 2012 · 68 citations · Full text

Medicine, Oncology, Pharmacology +13

Using learning analytics to evaluate a video-based lecture series

K. H. Vincent Lau, Pue Farooque, Gary Leydon et al. · Medical Teacher · 2017 · 64 citations

Education, Educational Assessment, Medical Education +17

Predictors of hematologic response and survival with stem cell transplantation in <scp>AL</scp> amyloidosis: A 25‐year longitudinal study

Joshua Gustine, Andrew Staron, Raphaël Szalat et al. · American Journal of Hematology · 2022 · 40 citations

Medicine, Hematology, Oncology +14

1–5 of 11